vs

Side-by-side financial comparison of DOCUSIGN, INC. (DOCU) and ResMed (RMD). Click either name above to swap in a different company.

ResMed is the larger business by last-quarter revenue ($1.4B vs $818.4M, roughly 1.7× DOCUSIGN, INC.). ResMed runs the higher net margin — 27.6% vs 10.2%, a 17.4% gap on every dollar of revenue. On growth, ResMed posted the faster year-over-year revenue change (11.0% vs 8.4%).

Docusign, Inc. is an American software company headquartered in San Francisco, California that provides products for organizations to manage electronic agreements with electronic signatures on different devices. As of 2025, Docusign has about 1.7 million clients in 180 countries. Signatures processed by Docusign are compliant with the US ESIGN Act and the European Union's eIDAS regulation, including EU Advanced and EU Qualified Signatures.

ResMed Inc. is a medical equipment company based in San Diego, California, and founded in Australia. It primarily provides cloud-connectable medical devices for the treatment of sleep apnea, chronic obstructive pulmonary disease (COPD), and other respiratory conditions. Resmed produced hundreds of thousands of ventilators and bilevel devices to help treat the respiratory symptoms of patients with COVID-19.

DOCU vs RMD — Head-to-Head

Bigger by revenue
RMD
RMD
1.7× larger
RMD
$1.4B
$818.4M
DOCU
Growing faster (revenue YoY)
RMD
RMD
+2.6% gap
RMD
11.0%
8.4%
DOCU
Higher net margin
RMD
RMD
17.4% more per $
RMD
27.6%
10.2%
DOCU

Income Statement — Q3 FY2026 vs Q4 FY2026

Metric
DOCU
DOCU
RMD
RMD
Revenue
$818.4M
$1.4B
Net Profit
$83.7M
$392.6M
Gross Margin
79.2%
61.8%
Operating Margin
10.4%
34.6%
Net Margin
10.2%
27.6%
Revenue YoY
8.4%
11.0%
Net Profit YoY
34.1%
13.9%
EPS (diluted)
$0.40
$2.68

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DOCU
DOCU
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.4B
Q4 25
$818.4M
$1.4B
Q3 25
$800.6M
$1.3B
Q2 25
$763.7M
$1.3B
Q1 25
$1.3B
Q4 24
$1.3B
Q3 24
$1.2B
Net Profit
DOCU
DOCU
RMD
RMD
Q2 26
$392.6M
Q1 26
$398.7M
Q4 25
$83.7M
$392.6M
Q3 25
$63.0M
$348.5M
Q2 25
$72.1M
$379.7M
Q1 25
$365.0M
Q4 24
$344.6M
Q3 24
$311.4M
Gross Margin
DOCU
DOCU
RMD
RMD
Q2 26
61.8%
Q1 26
62.2%
Q4 25
79.2%
61.8%
Q3 25
79.3%
61.5%
Q2 25
79.4%
60.8%
Q1 25
59.3%
Q4 24
58.6%
Q3 24
58.6%
Operating Margin
DOCU
DOCU
RMD
RMD
Q2 26
34.6%
Q1 26
34.9%
Q4 25
10.4%
34.6%
Q3 25
8.1%
33.4%
Q2 25
7.9%
33.7%
Q1 25
33.0%
Q4 24
32.5%
Q3 24
31.6%
Net Margin
DOCU
DOCU
RMD
RMD
Q2 26
27.6%
Q1 26
27.9%
Q4 25
10.2%
27.6%
Q3 25
7.9%
26.1%
Q2 25
9.4%
28.2%
Q1 25
28.3%
Q4 24
26.9%
Q3 24
25.4%
EPS (diluted)
DOCU
DOCU
RMD
RMD
Q2 26
$2.68
Q1 26
$2.74
Q4 25
$0.40
$2.68
Q3 25
$0.30
$2.37
Q2 25
$0.34
$2.58
Q1 25
$2.48
Q4 24
$2.34
Q3 24
$2.11

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DOCU
DOCU
RMD
RMD
Cash + ST InvestmentsLiquidity on hand
$583.3M
$1.4B
Total DebtLower is stronger
$663.8M
Stockholders' EquityBook value
$2.0B
$6.3B
Total Assets
$4.0B
$8.5B
Debt / EquityLower = less leverage
0.11×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DOCU
DOCU
RMD
RMD
Q2 26
$1.4B
Q1 26
$1.7B
Q4 25
$583.3M
$1.4B
Q3 25
$600.0M
$1.4B
Q2 25
$657.4M
$1.2B
Q1 25
$932.7M
Q4 24
$521.9M
Q3 24
$426.4M
Total Debt
DOCU
DOCU
RMD
RMD
Q2 26
$663.8M
Q1 26
$664.1M
Q4 25
$403.9M
Q3 25
$408.7M
Q2 25
$658.4M
Q1 25
$663.1M
Q4 24
$662.9M
Q3 24
$667.6M
Stockholders' Equity
DOCU
DOCU
RMD
RMD
Q2 26
$6.3B
Q1 26
$6.5B
Q4 25
$2.0B
$6.3B
Q3 25
$2.0B
$6.1B
Q2 25
$2.0B
$6.0B
Q1 25
$5.5B
Q4 24
$5.3B
Q3 24
$5.2B
Total Assets
DOCU
DOCU
RMD
RMD
Q2 26
$8.5B
Q1 26
$8.8B
Q4 25
$4.0B
$8.5B
Q3 25
$3.9B
$8.3B
Q2 25
$3.9B
$8.2B
Q1 25
$7.6B
Q4 24
$7.1B
Q3 24
$7.2B
Debt / Equity
DOCU
DOCU
RMD
RMD
Q2 26
0.11×
Q1 26
0.10×
Q4 25
0.06×
Q3 25
0.07×
Q2 25
0.11×
Q1 25
0.12×
Q4 24
0.13×
Q3 24
0.13×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DOCU
DOCU
RMD
RMD
Operating Cash FlowLast quarter
$290.3M
Free Cash FlowOCF − Capex
$262.9M
FCF MarginFCF / Revenue
32.1%
Capex IntensityCapex / Revenue
3.3%
Cash ConversionOCF / Net Profit
3.47×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DOCU
DOCU
RMD
RMD
Q2 26
Q1 26
Q4 25
$290.3M
$339.7M
Q3 25
$246.1M
$457.3M
Q2 25
$251.4M
$538.8M
Q1 25
$578.7M
Q4 24
$308.6M
Q3 24
$325.5M
Free Cash Flow
DOCU
DOCU
RMD
RMD
Q2 26
Q1 26
Q4 25
$262.9M
$311.2M
Q3 25
$217.6M
$414.4M
Q2 25
$227.8M
$508.2M
Q1 25
$557.9M
Q4 24
$288.0M
Q3 24
$307.7M
FCF Margin
DOCU
DOCU
RMD
RMD
Q2 26
Q1 26
Q4 25
32.1%
21.9%
Q3 25
27.2%
31.0%
Q2 25
29.8%
37.7%
Q1 25
43.2%
Q4 24
22.5%
Q3 24
25.1%
Capex Intensity
DOCU
DOCU
RMD
RMD
Q2 26
Q1 26
Q4 25
3.3%
2.0%
Q3 25
3.6%
3.2%
Q2 25
3.1%
2.3%
Q1 25
1.6%
Q4 24
1.6%
Q3 24
1.5%
Cash Conversion
DOCU
DOCU
RMD
RMD
Q2 26
Q1 26
Q4 25
3.47×
0.87×
Q3 25
3.91×
1.31×
Q2 25
3.49×
1.42×
Q1 25
1.59×
Q4 24
0.90×
Q3 24
1.05×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DOCU
DOCU

Subscription And Circulation$801.0M98%
Professional Services And Other$17.4M2%

RMD
RMD

Segment breakdown not available.

Related Comparisons